YBGJ (Yubo International Biotech) FCF Yield %: -54.38 (As of Jul. 04, 2026)


What is Yubo International Biotech FCF Yield %?

Yubo International Biotech YBGJ FCF Yield % is -54.38 as of Jul. 04, 2026. The stock has 2 warning signs investors should review. Among 857 Medical Devices & Instruments companies, Yubo International Biotech ranks worse than 92.18% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Yubo International Biotech's Trailing 12-Month Free Cash Flow is $-0.66 Mil, and Market Cap is $1.21 Mil. Therefore, Yubo International Biotech's FCF Yield % for today is -54.38%.

The historical rank and industry rank for Yubo International Biotech's FCF Yield % or its related term are showing as below:

YBGJ' s FCF Yield % Range Over the Past 10 Years
Min: -160   Med: -5.24   Max: -0.02
Current: -54.38


During the past 6 years, the highest FCF Yield % of Yubo International Biotech was -0.02%. The lowest was -160.00%. And the median was -5.24%.

YBGJ's FCF Yield % is ranked worse than
92.18% of 857 companies
in the Medical Devices & Instruments industry
Industry Median: -0.4 vs YBGJ: -54.38

Yubo International Biotech's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.


Yubo International Biotech FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Yubo International Biotech FCF Yield % Related Terms


Yubo International Biotech FCF Yield % Historical Data

* Premium members only.

The historical data trend for Yubo International Biotech's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yubo International Biotech FCF Yield % Chart

Yubo International Biotech Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Yield %
Get a 7-Day Free Trial -3.22 -5.63 -2.06 -32.23 -39.89

Yubo International Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -26.90 1.67 -62.88 -24.42 -32.18

YBGJ vs GCTK, ECIA, RSCF: FCF Yield % Comparison

For the Medical Instruments & Supplies subindustry, Yubo International Biotech's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yubo International Biotech FCF Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Yubo International Biotech's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Yubo International Biotech's FCF Yield % falls into.



Yubo International Biotech FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Yubo International Biotech's FCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-0.843 / 2.1132204
=-39.89%

Yubo International Biotech's annualized FCF Yield % for the quarter that ended in Mar. 2026 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.207 * 4 / 2.5733571
=-32.18%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -54.38 mean?
Yubo International Biotech (YBGJ) has a FCF Yield % of -54.38 as of Jul. 04, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Yubo International Biotech and its competitors. According to the industry distribution chart, Yubo International Biotech ranks #790 out of 857 companies in the Medical Devices & Instruments industry, placing it in the top 92.2%.
Is Yubo International Biotech's FCF Yield % too high?
Yubo International Biotech's current FCF Yield % is -54.38. Based on the distribution chart, Yubo International Biotech ranks #790 out of 857 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Yubo International Biotech's FCF Yield % compare to GCTK and ECIA?
According to the Medical Devices & Instruments industry distribution chart, Yubo International Biotech ranks #790 out of 857 companies for FCF Yield %. This places Yubo International Biotech in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Yubo International Biotech and its competitors. Yubo International Biotech's current FCF Yield % is -54.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yubo International Biotech stock overvalued right now?
Yubo International Biotech (YBGJ) has a current FCF Yield % of -54.38. The current FCF Yield % is -54.38. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Yubo International Biotech (YBGJ), the current FCF Yield % is -54.38 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Yubo International Biotech Business Description

Address No. 10 Chaoyang Park South Road, Room 1102, 11th Floor, Building 2, Chaoyang District, Beijing, CHN, 100026
Yubo International Biotech Ltd is a technology company focused on the research, development, and application of endometrial stem cells. It offers products and services under the brand VIVCELL. Its product offerings include healthcare products for the respiratory system, skincare products, hair care products, healthy beverages and male and female personal care products. It also offers stem cell-related services including cell testing and health management consulting services. The company derives its revenue from the sale of certain health management services and the sale of nebulizers containing frozen tubes with medical fluid. The nebulizers are sold directly to consumers on its online e-commerce platform.